Back
ESC2025 Premium Access

Amyloid-specific medication in transthyretin amyloid cardiomyopathy: a systemic review and meta-analysis.

Session: The evolving landscape of transthyretin amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Doctor M. Autherith (Vienna, AT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Maximilian Autherith

Medical University of Vienna, Vienna (Austria)
0 follower

5 more presentations in this session

Acoramidis reduces cardiovascular mortality (CVM): results at month 42 from the ATTRibute-CM open-label extension (OLE) study

Speaker: Assistant Professor K. Alexander (Palo Alto, US)

Access
Abstract
Slides
Video
Like
Thumbnail

ATTRv longevity variant: a novel clinical entity in the spectrum of cardiac amyloidosis

Speaker: Doctor J. Costantino (Rome, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Validation of red flags in cardiac amyloidosis across diagnostic modalities.

Speaker: Professor S. Spethmann (Berlin, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Variant-specific differences in hereditary transthyretin cardiac amyloidosis

Speaker: Mr S. Muller (Utrecht, NL) Doctor M. Oerlemans (Utrecht, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Renin-angiotensin-aldosterone system activity in transthyretin amyloid cardiomyopathy: implications for prognosis

Speaker: Doctor C. Kronberger (Vienna, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

The evolving landscape of transthyretin amyloidosis

Speakers: Doctor M. Autherith, Assistant Professor K. Alexander, Doctor J. Costantino, Professor S. Spethmann, Mr S. Muller...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources